Latest revenue
$7.1M
as of 2026-03-31
Latest net income
$-6.5M
as of 2026-03-31
Net margin
-90.5%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $18.9M
- Enterprise value
- $18.9M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $8.00
- 52-wk low
- $0.82
- Beta
- —
- Shares out
- 11.9M
5-year trend
About REED
Business description and risk factors will appear here once REED's latest filing is fully ingested.
Profitability
Gross margin
20.4%
31.8%Operating margin
-44.5%
108.0%Net margin
-46.5%
34.2%Return on equity
-173.1%
12.5%Return on assets
-67.9%
29.7%Leverage
Debt / equity
1.55×
44.3%Long-term debt / equity
-1.28×
34.4%Debt / assets
60.8%
17.3%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $7.1M | -28.8% | $-6.5M | -218.3% | -90.5% |
Q4 2025 2025-12-31 | $7.5M | -23.1% | $-3.8M | +8.2% | -50.5% |
Q3 2025 2025-09-30 | $7.0M | +4.2% | $-4.0M | +4.0% | -56.6% |
Q2 2025 2025-06-30 | $9.5M | -19.8% | $-6.0M | -88.3% | -63.5% |
Q1 2025 2025-03-31 | $10.0M | +4.5% | $-2.0M | -21.4% | -20.3% |
Q4 2024 2024-12-31 | $9.7M | — | $-4.1M | — | -42.3% |
Q3 2024 2024-09-30 | $6.8M | -43.0% | $-4.2M | -189.0% | -61.5% |
Q2 2024 2024-06-30 | $11.9M | +18.7% | $-3.2M | -2.5% | -27.1% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Bottled & Canned Soft Drinks & Carbonated Waters · SIC 2086
Your notes
Keep private notes on REED — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$0
Net activity
+$0
Distinct insiders
1
Open-market trades over the last 365 days.
Recent transactions
| Date | Insider | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| 2025-06-04 | Era Regenerative Medicine Ltd / D&D Source of Life Holding Ltd. 10%+ owner | Purchase | 1,075,269 | — | — |
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns REED
Institutional value
$453.1K
Total shares held
124.8K
Distinct holders
9
-5 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 82.2K | $298.5K | — | New |
| 2 | VANGUARD FIDUCIARY TRUST CO | 39.9K | $144.9K | — | New |
| 3 | UBS Group AG | 2.5K | $9.0K | -274 (-10.0%) | Trimmed |
| 4 | KELLEHER FINANCIAL ADVISORS | 116 | $421 | +0 (+0.0%) | No change |
| 5 | GROUP ONE TRADING LLC | 50 | $182 | +0 (+0.0%) | No change |
| 6 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 17 | $62 | +0 (+0.0%) | No change |
| 7 | Pacific Center for Financial Services | 16 | $59 | — | New |
| 8 | Steward Partners Investment Advisory, LLC | 3 | $11 | +0 (+0.0%) | No change |
| 9 | BFSG, LLC | 3 | $11 | +0 (+0.0%) | No change |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once REED's latest filing finishes processing.